相似文献
1
Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
J Infect Dis. 2019 Jul 31;220(5):730-734. doi: 10.1093/infdis/jiy682.
2
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.
3
Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
Vaccine. 2018 Jun 7;36(24):3498-3504. doi: 10.1016/j.vaccine.2018.04.075. Epub 2018 May 8.
4
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408. doi: 10.15585/mmwr.mm6549a5.
5
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874-882. doi: 10.15585/mmwr.mm6633a2.
6
Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.
MMWR Morb Mortal Wkly Rep. 2013 Jul 26;62(29):591-5.
7
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.
8
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1.
9
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
10
Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States.
Cancer. 2014 Oct 15;120(20):3200-7. doi: 10.1002/cncr.28871. Epub 2014 Jun 19.
引用本文的文献
1
Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry.
JMIR Form Res. 2025 May 30;9:e58163. doi: 10.2196/58163.
2
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2180250. doi: 10.1080/21645515.2023.2180250. Epub 2023 Feb 20.
3
Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2172276. doi: 10.1080/21645515.2023.2172276. Epub 2023 Feb 7.
4
An opportunity to increase human papillomavirus vaccination rates: Change the guidelines.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2136444. doi: 10.1080/21645515.2022.2136444. Epub 2022 Oct 25.
5
Disparities in awareness of the HPV vaccine and HPV-associated cancers among racial/ethnic minority populations: 2018 HINTS.
Ethn Health. 2023 May;28(4):586-600. doi: 10.1080/13557858.2022.2116630. Epub 2022 Aug 31.
6
Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework.
J Behav Med. 2023 Apr;46(1-2):356-365. doi: 10.1007/s10865-022-00296-4. Epub 2022 Feb 22.
7
Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
Vaccine. 2022 Jan 24;40(3):471-476. doi: 10.1016/j.vaccine.2021.12.003. Epub 2021 Dec 13.
8
What do Young People Think About HPV and HPV Vaccination? The Role of Health Education Interventions and Health Professionals.
Mater Sociomed. 2021 Sep;33(3):219-224. doi: 10.5455/msm.2021.33.219-224.
9
Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
Vaccine. 2021 Jun 11;39(26):3528-3535. doi: 10.1016/j.vaccine.2021.04.055. Epub 2021 May 19.
10
Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
Hum Vaccin Immunother. 2021 Sep 2;17(9):3077-3080. doi: 10.1080/21645515.2021.1912550. Epub 2021 May 7.
本文引用的文献
1
Youth Risk Behavior Surveillance - United States, 2017.
MMWR Surveill Summ. 2018 Jun 15;67(8):1-114. doi: 10.15585/mmwr.ss6708a1.
2
Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007-2014.
Vaccine. 2018 May 31;36(23):3381-3386. doi: 10.1016/j.vaccine.2018.03.045. Epub 2018 May 4.
3
Operationalizing outcome measures of human papillomavirus vaccination among adolescents.
Public Health. 2018 Jun;159:129-132. doi: 10.1016/j.puhe.2018.02.022. Epub 2018 Mar 30.
4
Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.
J Infect Dis. 2018 Jun 5;218(1):109-113. doi: 10.1093/infdis/jiy165.
5
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2018.
MMWR Morb Mortal Wkly Rep. 2018 Feb 9;67(5):156-157. doi: 10.15585/mmwr.mm6705e2.
6
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874-882. doi: 10.15585/mmwr.mm6633a2.
7
Sexual Activity and Contraceptive Use Among Teenagers in the United States, 2011-2015.
Natl Health Stat Report. 2017 Jun(104):1-23.
8
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408. doi: 10.15585/mmwr.mm6549a5.
9
Penises not required: a systematic review of the potential for human papillomavirus horizontal transmission that is non-sexual or does not include penile penetration.
Sex Health. 2016 Feb;13(1):10-21. doi: 10.1071/SH15089.
10
Going most of the way: "technical virginity" among American adolescents.
Soc Sci Res. 2008 Dec;37(4):1200-15. doi: 10.1016/j.ssresearch.2007.09.006.
Zotero 插件